5 Amino 1mq

5‑Amino‑1‑MQ (5‑Amino‑1‑Methylquinolinium) is a novel small molecule derived from quinolinium salts that has been studied for its ability to inhibit NNMT (Nicotinamide N‑Methyltransferase), an enzyme involved in metabolic dysfunction, obesity, and cellular aging. By downregulating NNMT activity, research shows 5‑Amino‑1MQ may support increased NAD⁺ availability, enhanced mitochondrial function, and improved metabolic efficiency. In cell and animal models, this mechanism has been linked to:

• Higher energy expenditure
• Improved insulin sensitivity
• Reduced fat accumulation
• Cellular senescence and aging-pathway research

Because of its role in the NAD⁺ salvage pathway, 5‑Amino‑1MQ is increasingly studied alongside other longevity molecules like NMN, NR, and resveratrol, but with a more direct effect on the gene associated with metabolic slowdown.

Researchers are exploring 5‑Amino‑1MQ because it:

• Targets root-level metabolic decline via NNMT inhibition
• Supports energy production and fat oxidation in vitro
• mproves insulin sensitivity, a key marker in metabolic health
• Offered in oral capsules for convenience and injectable powder for rapid uptake
• Lab-tested, 99%+ purity, and available for advanced metabolic research protocols

Its flexibility makes it ideal for varied research setups — whether targeting age-related metabolic shifts, obesity studies, or cellular energy pathways.

What makes 5-Amino-1MQ unique in the peptide research landscape is its genetic-level modulation of metabolic function — not just symptoms. By silencing NNMT, it enables a natural uptick in NAD⁺ levels, leading to enhanced mitochondrial function, lean mass preservation, and fat metabolism without overstimulation.

• Unlike traditional fat-burners or stimulants, it doesn’t spike cortisol or heart rate
• It directly impacts the epigenetic drivers of aging and weight gain
• Real Peptides offers both oral and injectable forms, letting researchers tailor to their desired absorption curve and study design

In longevity and metabolic studies, 5-Amino-1MQ stands out as a clean, versatile molecule backed by growing interest in NAD⁺-based therapeutics.